FDA Investigator Kendra L Brooks

Kendra L Brooks has conducted inspections on 76 sites in 2 countries as of 27 Mar 2015. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
76
Last Inspection Date:
27 Mar 2015
Investigator Role:
FDA Investigator
Redica ID:
100008105
Countries of Inspections:
United States of America, Italy
FDA Investigators that have inspected at least one site in common with Kendra L Brooks:
Adena S Yau, Adetutu M Gidado, Akilah K Green, Albert A Salvador, Alison N Correll, Alison N Stieg, Allison A Aldridge, PhD, Amy M Codella, Amy M Cramer, Anastasia I Offordile, Anastasia M Shields, Anita R Michael, Ann Marie Montemurro, Anne E Johnson, Anthony A Charity, Audrey Thereset Uy, Barbara A Kitay, Bijoy Panicker, Brian D Young, Brian L Szcyubialka, Brian S Keefer, Carol A Robles, Charles R Bonapace, PhD, Christina K Theodorou, Colleen M Damon, Craig D Zagata, Crayton Lee, Cynthia A Palmer, Cynthia White, Daniel J Deciero, Daniel J Min, Daniel W Johnson, Dauksism, David A Oluwo, David J Hafner, Deborah H Cozzone, Deborah J Parris, Deborah K Richardson, Debra J Bennett, Debra L Pagano, Denise M Digiulio, Derek S Dealy, Dr. Mark J Seaton, PhD, Edward D Mcdonald, Edwin L Hobbs, Erika M Wilkerson, Erin D Mccaffery, Evan Tong, Gayle S Lawson, Gerald W Kopp, Giovanni A Vigilante, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, Heriberto Negron Rivera, Howard B Rabinovitch, Jacob M Dyer, James M Mason, James P Mcevoy, Javier E Santos, Jazmine N Brown, Jeannie R Mayberry, Jeen S Min, Joanne Heim, Jose M Cayuela, Joseph L Despins, PhD, Joseph S Fanelli, Joseph T Dougherty, Juanita P Versace, Judith A Paterson, Julianne C Mccullough, Junho Pak, Kalavati Suvarna, PhD, Karen A Briggs, Karthik B Iyer, Karyn M Campbell, Kendra A Biddick, Kim Crayton, Kim G Campbell, Ko U Min, Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, Kyle D Covill, Kyle S Hobson, L Zam Lam, Laishan L Lam, Lakshmi Narasimhan, PhD, Lance Mde Souza, MBA, LCDR Margaret Edi Gennaro, LCDR Susan E Polifko, Linda M Hoover, Lisa B Hall, Lisa B Orr, Lisa M Bellows, Lori A Rose, LT John M Mastalski, LTJG Bradley E Benasutti, LTJG Lauren N Shade, Luis A Dasta, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia Gelber, Margaret Faulkner, Maria A Reed, Maria Estrella, Martha Sullivan Myrick, Mary Davis Lopez, Matthew R Noonan, Maureen A Wentzel, Meena Bansal Gupta, PhD, Meredith L Sheridan, Michael A Taylor, Michael Gurbarg, Michael J Nerz, Michael L Casner, Michael R Klapal, Michael Rosner, Michele Gottshall, Mike M Rashti, Monika Borkowska, Nicholas A Violand, Nikhil Thakur, Nikisha M Bolden, Pamela M Tremarki, Patricia F Hughes, PhD, Patrick C Klotzbuecher, Princess R Campbell, Qin Xu, Rachael O Oyewole, Raffi B Papazian, Reyes Candau Chacon, PhD, Robert G Ruff, Robert J Maffei, Robert Maffei, Robin P Mathew, Ronald A Stokes, Ronald T Colucci, Rose Ljean Mary, Russell P Vandermark, Ruth A Oni, Saleem A Akhtar, Sam Pepe, Seng Ching Hwang, Sharon Mills, Shirley J Berryman, Stephanie Mangigian, MS/OSH, RN, Stephen J Koniers, Steven E Kane, Susan F Laska, MS, Syeda N Mahazabin, Tamara L Ely, Tammy L Chavis, Tammy M Phillips, Tania E Vizcaino, Teigan M Mule, Tekalign Wondimu, Temar Q Williams, Thomas E Friel, Tiffani D Wilson, Todd J Maushart, Tonya O Corbin, Van Cliff, Vlada Matusovsky, Walter L Fava, Whitney S Reynolds, Yessika Mashinski, Yvesna C Blaise, Yvonne C Mcknight, Yvonne C Wood, Zhongren Wu

Kendra L Brooks's Documents

Publish Date Document Type Title
July, 2014 EIR Frank Balis - EIR, 2014-07-07
February, 2013 EIR Powdersize, LLC - EIR, 2013-02-26
January, 2010 FDA 483 Laboratory Testing Inc. - Form 483, 2010-01-08
March, 2012 EIR Johnson Matthey Inc. - EIR, 2012-03-27
February, 2013 FDA 483 Powdersize, LLC - Form 483, 2013-02-26
January, 2010 FDA 483 Howard C. Herrmann, M.d. - Form 483, 2010-01-28
December, 2013 FDA 483 Merck Sharp & Dohme Corp. - Form 483, 2013-12-20
August, 2012 FDA 483 Lannett Company, Inc. - Form 483, 2012-08-17
January, 2010 EIR Howard C. Herrmann, M.d. - EIR, 2010-01-28
December, 2013 EIR Merck Sharp & Dohme Corp. - EIR, 2013-12-20
March, 2014 EIR Sigmapharm Laboratories, LLC - EIR, 2014-03-20
January, 2013 FDA 483 Teva Branded Pharmaceutical Products R&D - Form 483, 2013-01-30
February, 2015 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2015-02-11
March, 2015 EIR Amedra Pharmaceuticals LLC - EIR, 2015-03-11
March, 2012 FDA 483 Johnson Matthey Inc. - Form 483, 2012-03-29
January, 2013 EIR Teva Branded Pharmaceutical Products R&D - EIR, 2013-01-30
September, 2011 EIR Azur Pharma, Inc. - EIR, 2011-09-27
July, 2013 FDA 483 Accupac, LLC - Form 483, 2013-07-19
January, 2013 FDA 483 Response Teva Branded Pharmaceutical Products R&D - Form 483R, 2013-02-21
March, 2015 FDA 483 Amedra Pharmaceuticals LLC - Form 483, 2015-03-11
March, 2015 FDA 483 Response Amedra Pharmaceuticals LLC - Form 483R, 2016-02-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more